Barboza, Nora M <br/><br/>
Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab.  [electronic resource] 

 -  Cancer biology & therapy  Jan 2012 
 - 114-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1555-8576 
<br/><br/><label>Standard No.: </label>10.4161/cbt.13.2.18876  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal, Murine-Derived--administration & dosage<br/>Antigens, CD20--genetics<br/>Antineoplastic Agents--administration & dosage<br/>Apoptosis--drug effects<br/>Burkitt Lymphoma--drug therapy<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Depsipeptides--administration & dosage<br/>Female<br/>Humans<br/>Immunophenotyping<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Mice<br/>Mice, Nude<br/>Peptides, Cyclic<br/>Rituximab<br/>Xenograft Model Antitumor Assays